Back to BMY Stock Lookup

BMY Related FDA

Apr 23, 2013 08:35 AM Vertex Pharma (VRTX) Reports Significant Data from VX-135 in HCV RNA

Apr 22, 2013 07:39 AM Merck (MRK), Bristol-Myers Squib (BMY) Partner on Hepatitis C Combo

Apr 5, 2013 08:02 AM Vertex (VRTX) Enters non-Exclusive Pact with Bristol-Myers (BMY) for VX-135 Phase 2

Apr 1, 2013 11:47 AM Amarin's (AMRN) Vascepa Tracking Well 3-Months In; Investors Eye Tier 2 Designation

Mar 14, 2013 05:43 PM FDA to Review Certain Diabetes Drugs Over New Pancreas Concern (BMY) (LLY) (MRK)

Feb 8, 2013 10:11 AM Medicines Co (MDCO) Reports Recothrom License is Now Effective (BMY)

Jan 4, 2013 05:45 AM Tranzyme Pharma (TZYM) Completes Collaboration w/ Bristol-Myers (BMY)

Jan 2, 2013 08:03 AM ELIQUIS Receives FDA Approval in Reducing Certain Risks in Nonvalvular Atrial Fibrillation

Dec 28, 2012 04:14 PM Pfizer (PFE) and Bristol-Meyers (BMY) win FDA approval for Eliquis

Dec 26, 2012 07:30 AM Bristol-Myers (BMY), Pfizer (PFE) Receive Approval for ELIQUIS in Japan

Dec 12, 2012 07:02 AM The Medicines Co (MDCO) and Bristol-Myers Squibb (BMY) Enter Collaboration on Recothrom

Dec 3, 2012 01:45 PM Bristol-Myers (BMY) to terminate Avagacestat clinical developmen

Nov 20, 2012 01:55 PM Bristol-Myers (BMY), Pfizer (PFE) Receive EC Approval for ELIQUIS

Nov 14, 2012 11:55 AM Bristol-Myers (BMY), AstraZeneca (AZN) Receive EC Approval for Forxiga

Nov 12, 2012 03:31 PM Bristol-Myers (BMY) Says Peginterferon Achieved PDR in D-LITE Phase IIb

Nov 12, 2012 09:05 AM Bristol-Myers (BMY) Says Orencia Similar to Humira + MTX in PROs with RA

Oct 15, 2012 03:49 PM Bristol-Myers (BMY) Gets FDA Approval for Expanded BARACLUDE Indication

Oct 4, 2012 03:17 PM NACF Conference Could Create Catalyst for Vertex (VRTX) - Analyst

Oct 3, 2012 08:34 AM Sanofi (SNY) to Gain Back Plavix, Avapro/Avalide Rights, Pay Bristol-Myers (BMY) Royalty Fees

Sep 26, 2012 05:03 PM Bristol-Myers (BMY), Pfizer (PFE) Report FDA Acknowledgment of ELIQUIS NDA Resubmission

Sep 21, 2012 08:32 AM Vanderbilt, Bristol-Myers (BMY) Enter Parkinson’s Disease Treatment Development Collaboration

Aug 31, 2012 01:26 PM Akamai (AKAM) Wins Appeal in Content Delivery Patent Case vs. Limelight (LLNW)

Aug 28, 2012 03:42 PM Barclays on U.S. Biopharmaceuticals: Fate of Nucs Under Harsh Scrutiny - More Angst for IDIX; GILD Widens Lead

Aug 27, 2012 08:56 AM Idenix Pharma (IDIX) Peers on Watch as FDA Places Clinical Hold on Another HCV Treatment (ACHN) (GILD)

Aug 24, 2012 08:53 AM Bristol-Myers (BMY) Stock Drops 10% in Less than Month as Hepatitis C Drug Proves Dangerous

Aug 24, 2012 07:46 AM Bristol-Myers Squibb (BMY) to Take $1.8B Non-Cash Charge on Hep C Development Halt

Aug 24, 2012 06:45 AM Bristol-Myers (BMY) Discontinues Development of Hep C Treatment BMS-986094

Aug 17, 2012 02:54 PM Barclays Lowers Outlook on Idenix Pharmaceuticals (IDIX); Clarity on FDA Clinical Hold (BMY, VRTX, GILD)

Aug 17, 2012 08:46 AM Leerink Swann maintains an 'Outperform' on Idenix Pharmaceuticals (IDIX); Clinical Hold Feels More Like Precaution

Aug 15, 2012 08:01 AM Bristol-Myers Squibb (BMY), Otsuka America Launch Sprycel Patient Management Programs

Aug 9, 2012 07:46 AM Bristol-Myers (BMY), AstraZeneca (AZN) Make Initial $3.2B Payment to Amylin Pharma; AstraZeneca Exercises Rights Option

Aug 2, 2012 01:44 PM UBS on Bristol-Myers Squibb's (BMY) INX-189 Stumble: At Best Puts Bristol Behind; At Worst, Out of the Race

Aug 2, 2012 10:38 AM Gilead Sciences (GILD) Surges As Bristol-Myers' (BMY) Hep C Drug Has Major Setback

Jul 19, 2012 04:34 PM Bristol-Myers Squibb (BMY) Says Phase III BRISK-FL Missed Primary Endpoint

Jul 9, 2012 06:48 AM Eli Lilly (LLY), Bristol-Myers Squibb (BMY) ERBITUX w/ FOLFIRI Granted Full-Approval by FDA

Jun 25, 2012 10:10 AM Bristol-Myers (BMY), Pfizer (PFE) See $5B of Market Cap Evaporate Following CRL on ELIQUIS

Jun 25, 2012 07:32 AM Bristol-Myers (BMY), Pfizer (PFE) Get CRL from FDA for ELIQUIS NDA; More Info Needed

Jun 11, 2012 07:23 AM Bristol-Myers (BMY), AstraZeneca (AZN) Report Significant Data from Dapagliflozin Phase 3 in HbA1c Reduction for Type 2 Diabetes Patients

Jun 6, 2012 07:27 AM Bristol-Myers Squibb (BMY) Says AMPLE Met Primary Endpoint in Biologic-Naïve RA Patients

May 15, 2012 11:17 AM Bristol-Myers (BMY) Announces FDA Approval of Devens, MA Plant for Manufacture of ORENCIA

Apr 23, 2012 01:21 PM Brean Murray Carret & Co. maintains a 'Buy' on Achillion Pharmaceuticals (ACHN); Removes From N-T Focus List, But Dip Offers Investor Opportunity

Apr 19, 2012 03:17 PM Brean Murray Carret & Co. Out In Defense of Achillion Pharmaceuticals (ACHN); Superficial Read-Through

Mar 1, 2012 06:41 AM FDA Extends Action Date for Bristol-Myers' (BMY) and Pfizer's (PFE) Eliquis NDA

Feb 8, 2012 06:52 AM Sanofi (SNY), Bristol-Myers Squibb (BMY) Get $442.2M Payment from Plavix Settlement

Jan 19, 2012 06:43 AM Bristol-Myers (BMY), AstraZeneca (AZN) Get Complete Response from FDA for Dapagliflozin; More Info Requested

Jan 18, 2012 05:03 PM Bristol-Myers Squibb (BMY) Publishes Data on HCV Phase II for Null Responders; Primary Endpoint Sustained

Dec 22, 2011 04:31 PM Bristol-Myers Squibb (BMY) Reports Phase III BRISK-PS Missed Primary Endpoint

Dec 22, 2011 01:31 PM Bristol-Myers Squibb (BMY), Gladstone Enter Collaboration to ID Novel Targets in Alzheimer’s Disease

Dec 8, 2011 06:50 AM Bristol-Myers (BMY), Astra Zeneca (AZN) Report Positive Data for Dapagliflozin in Type 2 Diabetes Trial

Dec 2, 2011 07:32 AM Bristol-Myers Squibb (BMY) Enters Daclatasvir Collaboration with Tibotec Pharma

Back to BMY Stock Lookup